AMI    Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK) Heart (2008) 94; 329-35 R. Zahn, M. Gottwik, M. Hochadel, J. Senges, U. Zeymer, A. Vogt, T. Meinertz, R. Dietz, K. E. Hauptmann, E. Grube, S. Kerber and U. Sechtem Comparison of accuracy in the prediction of left ventricular wall motion changes between invasively assessed microvascular integrity indexes and fluorine-18 fluorodeoxyglucose positron emission tomography in patients with ST-elevation myocardial infarction Am J Cardiol (2008) 102; 129-34 M. H. Yoon, S. J. Tahk, H. M. Yang, S. I. Woo, H. S. Lim, S. J. Kang, B. J. Choi, S. Y. Choi, G. S. Hwang and J. H. Shin Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial Am Heart J (2009) 157; 60 e1-9 G. Yong, J. Rankin, L. Ferguson, J. Thom, J. French, D. Brieger, D. P. Chew, R. Dick, D. Eccleston, B. Hockings, D. Walters, A. Whelan and J. W. Eikelboom B-type natriuretic peptide: a treatment, not a diagnostic marker Heart (2008) 94; 542-4 G. W. Yip Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice Am J Cardiol (2008) 101; 919-24 R. T. Yan, A. T. Yan, C. B. Granger, J. Lopez-Sendon, D. Brieger, B. Kennelly, A. Budaj, P. G. Steg, A. A. Georgescu, Q. Hassan and S. G. Goodman An analysis of door-to-balloon time in a single center to determine causes of delay and possibilities for improvement Catheter Cardiovasc Interv (2008) 71; 152-7 E. B. Wu, N. Arora, A. C. Eisenhauer and F. S. Resnic Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study E Heart (2008) 94; 730-6 . Wu, J. T. Ortiz, P. Tejedor, D. C. Lee, C. Bucciarelli-Ducci, P. Kansal, J. C. Carr, T. A. Holly, D. Lloyd-Jones, F. J. Klocke and R. O. Bonow Perusal of risk stratification of acute myocardial infarction for half a century Eur Heart J (2009) K. S. Woo Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet (2008) 371; 1353-63 S. D. Wiviott, E. Braunwald, C. H. McCabe, I. Horvath, M. Keltai, J. P. Herrman, F. Van de Werf, W. E. Downey, B. M. Scirica, S. A. Murphy and E. M. Antman Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients Eur Heart J (2008) K. Winkler, C. Wanner, C. Drechsler, J. Lilienthal, W. Marz and V. Krane Routine use of oxygen in the treatment of myocardial infarction: systematic review Heart (2009) 95; 198-202 M. Wijesinghe, K. Perrin, A. Ranchord, M. Simmonds, M. Weatherall and R. Beasley Familial-combined hyperlipidaemia in very young myocardial infarction survivors (<=40 years of age) Eur Heart J (2009) F. Wiesbauer, H. Blessberger, D. Azar, G. Goliasch, O. Wagner, L. Gerhold, K. Huber, K. Widhalm, F. Abdolvahab, G. Sodeck, G. Maurer and M. Schillinger Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol (2008) 51; 1734-41 H. D. White, D. P. Chew, J. W. Hoekstra, C. D. Miller, C. V. Pollack, Jr., F. Feit, A. M. Lincoff, M. Bertrand, S. Pocock, J. Ware, E. M. Ohman, R. Mehran and G. W. Stone Acute myocardial infarction Lancet (2008) 372; 570-84 H. D. White and D. P. Chew Evolution of the definition of myocardial infarction: what are the implications of a new universal definition? Heart (2008) 94; 679-84 H. D. White Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study Heart (2008) 94; 1141-6 L. Wei, C. C. Lang, F. M. Sullivan, P. Boyle, J. Wang, S. D. Pringle and T. M. MacDonald Simulation-based education improves quality of care during cardiac arrest team responses at an academic teaching hospital: a case-control study Chest (2008) 133; 56-61 D. B. Wayne, A. Didwania, J. Feinglass, M. J. Fudala, J. H. Barsuk and W. C. McGaghie Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography Am Heart J (2009) 157; 716-23 T. Y. Wang, M. Zhang, Y. Fu, P. W. Armstrong, L. K. Newby, C. M. Gibson, D. J. Moliterno, F. Van de Werf, H. D. White, R. A. Harrington and M. T. Roe Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database Eur Heart J (2008) 29; 2981-8 K. Walters, G. Rait, I. Petersen, R. Williams and I. Nazareth C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study Eur Heart J (2009) A. A. Voors, S. von Haehling, S. D. Anker, H. L. Hillege, J. Struck, O. Hartmann, A. Bergmann, I. Squire, D. J. van Veldhuisen and K. Dickstein Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction Eur Heart J (2008) 29; 241-50 S. Voo, J. Eggermann, M. Dunaeva, C. Ramakers-van Oosterhoud and J. Waltenberger Intensity of physical exertion and triggering of myocardial infarction: a case-crossover study Eur Heart J (2008) 29; 1881-8 S. von Klot, M. A. Mittleman, D. W. Dockery, M. Heier, C. Meisinger, A. Hormann, H. E. Wichmann and A. Peters Ischaemic stroke and myocardial infarction in a Caucasian patient with Moya-Moya disease Eur Heart J (2008) 29; 842 C. von Bary, T. Liebig, J. Gaa and N. von Beckerath Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial Eur Heart J (2009) 30; 594-9 M. Vogelzang, P. J. Vlaar, T. Svilaas, D. Amo, M. W. Nijsten and F. Zijlstra Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study Lancet (2008) 371; 1915-20 P. J. Vlaar, T. Svilaas, I. C. van der Horst, G. F. Diercks, M. L. Fokkema, B. J. de Smet, A. F. van den Heuvel, R. L. Anthonio, G. A. Jessurun, E. S. Tan, A. J. Suurmeijer and F. Zijlstra The feasibility and safety of routine thrombus aspiration in patients with non-ST-elevation myocardial infarction Catheter Cardiovasc Interv (2008) 72; 937-42 P. J. Vlaar, G. F. Diercks, T. Svilaas, M. Vogelzang, B. J. de Smet, A. F. van den Heuvel, R. L. Anthonio, G. A. Jessurun, E. S. Tan, A. J. Suurmeijer and F. Zijlstra Acute myocardial infarction after football chest trauma: management guided by intravascular ultrasound Eur Heart J (2009) 30; 739 D. Vivas, L. Hernando and A. Fernandez-Ortiz Local hospital vs. core-laboratory interpretation of the admission electrocardiogram in acute coronary syndromes: increased mortality in patients with unrecognized ST-elevation myocardial infarction Eur Heart J (2008) 29; 31-7 R. Vijayaraghavan, A. T. Yan, M. Tan, D. H. Fitchett, A. A. Georgescu, Q. Hassan, A. Langer and S. G. Goodman Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients Catheter Cardiovasc Interv (2008) 72; 927-33 E. Varani, M. Balducelli, M. Aquilina, G. Vecchi, M. N. Hussien, V. Frassineti and A. Maresta Factor XIII: the cement of the heart after myocardial infarction? Eur Heart J (2008) 29; 427-8 D. Vanhoutte and S. Heymans The challenge of reducing time to reperfusion in patients with acute ST elevation myocardial infarction Eur Heart J (2008) 29; 1793-4 A. W. van 't Hof Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J (2008) 29; 2909-45 F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, A. Kastrati, A. Rosengren, P. G. Steg, M. Tubaro, F. Verheugt, F. Weidinger, M. Weis, A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, F. V. Aguirre, N. Al-Attar, E. Alegria, F. Andreotti, W. Benzer, O. Breithardt, N. Danchin, C. Di Mario, D. Dudek, D. Gulba, S. Halvorsen, P. Kaufmann, R. Kornowski, G. Y. Lip and F. Rutten The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation Eur Heart J (2008) 29; 1714-20 T. Uetani, T. Amano, H. Ando, K. Yokoi, K. Arai, M. Kato, N. Marui, M. Nanki, T. Matsubara, H. Ishii, H. Izawa and T. Murohara Prophylactic use of hemodialysis to prevent radiocontrast-induced nephropathy: the discussion is open again J Am Coll Cardiol (2008) 51; 1047-8; author reply 48 D. E. Uehlinger Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial) Am J Cardiol (2008) 101; 1523-30 K. R. Tuttle, L. A. Shuler, D. P. Packard, J. E. Milton, K. B. Daratha, D. M. Bibus and R. A. Short Missed opportunities for reperfusion therapy for ST-segment elevation myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) Am Heart J (2008) 155; 471-7 study A. J. Tricomi, D. J. Magid, J. S. Rumsfeld, D. R. Vinson, E. E. Lyons, L. Crounse, P. M. Ho, P. N. Peterson and F. A. Masoudi The timing of development and subsequent clinical course of heart failure after a myocardial infarction Eur Heart J (2008) 29; 859-70 A. Torabi, J. G. Cleland, N. K. Khan, P. H. Loh, A. L. Clark, F. Alamgir, J. L. Caplin, A. S. Rigby and K. Goode Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study) Am J Cardiol (2009) 103; 577-82 M. J. Tikkanen, I. Holme, N. B. Cater, M. Szarek, O. Faergeman, J. J. Kastelein, A. G. Olsson, M. L. Larsen, C. Lindahl and T. R. Pedersen Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial Circulation (2008) 118; 49-57 H. Thiele, K. Schindler, J. Friedenberger, I. Eitel, G. Furnau, E. Grebe, S. Erbs, A. Linke, S. Mobius-Winkler, D. Kivelitz and G. Schuler Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration Am J Cardiol (2009) 103; 29-35 C. J. Terkelsen, C. Oxvig, B. L. Norgaard, S. Glerup, T. S. Poulsen, J. F. Lassen, H. J. Moller, L. Thuesen, E. Falk, T. T. Nielsen and H. R. Andersen Value of ST-resolution analysis in the era of primary percutaneous coronary intervention Heart (2008) 94; 13-5 C. J. Terkelsen and H. R. Andersen Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myocardial infarction Am J Cardiol (2008) 101; 419-21 M. Terashima, S. Fujiwara, G. Y. Yaginuma, K. Takizawa, U. Kaneko and T. Meguro Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial Eur Heart J (2009) M. Tendera, W. Wojakowski, W. Ruzyllo, L. Chojnowska, C. Kepka, W. Tracz, P. Musialek, W. Piwowarska, J. Nessler, P. Buszman, S. Grajek, P. Breborowicz, M. Majka and M. Z. Ratajczak Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome Am J Cardiol (2008) 102; 653-7 U. U. Tamhane, S. Aneja, D. Montgomery, E. K. Rogers, K. A. Eagle and H. S. Gurm Eighteen year (1985-2002) analysis of incidence, mortality, and cardiac procedure outcomes of acute myocardial infarction in patients > or = 65 years of age Am J Cardiol (2008) 101; 930-6 S. M. Tahir, L. L. Price, P. B. Shah and F. G. Welt Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J (2009) 30; 321-9 P. G. Steg, K. A. Fox, K. A. Eagle, M. Furman, F. Van de Werf, G. Montalescot, S. G. Goodman, A. Avezum, W. Huang and J. M. Gore Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Circulation (2008) 117; 2104-13 S. D. Solomon, J. Wittes, P. V. Finn, R. Fowler, J. Viner, M. M. Bertagnolli, N. Arber, B. Levin, C. L. Meinert, B. Martin, J. L. Pater, P. E. Goss, P. Lance, S. Obara, E. Y. Chew, J. Kim, G. Arndt and E. Hawk Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction Am Heart J (2008) 155; 55 e1-9 S. Solheim, I. Seljeflot, K. Lunde, P. Aukrust, A. Yndestad, H. K. Grogaard, S. Aakhus, K. Forfang and H. Arnesen Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery J Am Coll Cardiol (2008) 51; 1044-6 K. D. Sjauw, M. Remmelink, J. Baan, Jr., K. Lam, A. E. Engstrom, R. J. van der Schaaf, M. M. Vis, K. T. Koch, J. P. van Straalen, J. G. Tijssen, B. A. de Mol, R. J. de Winter, J. J. Piek and J. P. Henriques A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J (2009) 30; 459-68 K. D. Sjauw, A. E. Engstrom, M. M. Vis, R. J. van der Schaaf, J. Baan, Jr., K. T. Koch, R. J. de Winter, J. J. Piek, J. G. Tijssen and J. P. Henriques Effect of prehospital triage on revascularization times, left ventricular function, and survival in patients with ST-elevation myocardial infarction Am J Cardiol (2009) 103; 907-12 G. Sivagangabalan, A. T. Ong, A. Narayan, N. Sadick, P. S. Hansen, G. C. Nelson, M. Flynn, D. L. Ross, S. C. Boyages and P. Kovoor Intraoperative myocardial infarction in non-cardiac surgery: is a universal definition feasible? Eur Heart J (2008) 29; 567; author reply 67-8 E. Siniorakis, G. Kirvassilis and N. Exadactylos Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality J Am Coll Cardiol (2008) 52; 1041-8 M. H. Shishehbor, S. S. Goel, S. R. Kapadia, D. L. Bhatt, P. Kelly, R. E. Raymond, J. M. Galla, S. J. Brener, P. L. Whitlow and S. G. Ellis Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age Am J Cardiol (2008) 101; 1531-6 S. Setoguchi, D. H. Solomon, R. Levin and W. C. Winkelmayer Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population Eur Heart J (2009) 30; 436-43 B. Schweikert, M. Hunger, C. Meisinger, H. H. Konig, O. Gapp and R. Holle Contact-to-balloon time and door-to-balloon time after initiation of a formalized data feedback in patients with acute ST-elevation myocardial infarction Am J Cardiol (2008) 101; 46-52 K. H. Scholz, R. Hilgers, D. Ahlersmann, H. Duwald, R. Nitsche, G. von Knobelsdorff, B. Volger, K. Moller and F. K. Keating Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications Eur Heart J (2008) J. Schmitt, G. Duray, B. J. Gersh and S. H. Hohnloser Changes in management of elderly patients with myocardial infarction Eur Heart J (2009) F. Schiele, N. Meneveau, M. F. Seronde, V. Descotes-Genon, J. Oettinger, F. Ecarnot and J. P. Bassand Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation Heart (2008) 94; 311-5 J. Sanchis, X. Bosch, V. Bodi, N. Bellera, J. Nunez, B. Benito, J. Ordonez, L. Consuegra, M. Heras and A. Llecer Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality Heart (2009) 95; 370-6 F. Saia, C. Marrozzini, P. Ortolani, T. Palmerini, P. Guastaroba, P. Cortesi, P. C. Pavesi, G. Gordini, L. G. Pancaldi, N. Taglieri, G. di Pasquale, A. Branzi and A. Marzocchi Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty Catheter Cardiovasc Interv (2008) 71; 759-63 M. Romano, F. Buffoli, L. Tomasi, L. Corrado, M. R. Ferrari and R. Zanini Coronary thrombectomy by retrieval of an open emboli-protection filter device Heart (2008) 94; 274 I. Reho, C. Gruner and M. Roffi Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology Eur Heart J (2008) 29; 277-8 C. Rapezzi, E. Biagini and A. Branzi Cytochrome P450 2C19 polymorphism and clopidogrel after MI Lancet (2009) 373; 1172; author reply 72-3 R. Ramaraj Risk factors for myocardial infarction in women and men Eur Heart J (2009) R. Ramaraj Glucose-lowering therapy after myocardial infarction: more questions than answers Eur Heart J (2008) 29; 141-3 P. W. Radke and H. Schunkert Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction J Am J Cardiol (2009) 103; 461-3 . C. Quinaglia e Silva, D. B. Munhoz, T. N. Morato, A. Gurgel, A. C. Macedo, P. Sever and A. C. Sposito Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study Heart (2009) 95; 476-82 C. Pristipino, C. Trani, M. S. Nazzaro, A. Berni, G. Patti, R. Patrizi, B. Pironi, P. Mazzarotto, G. Gioffre, G. G. Biondi-Zoccai and G. Richichi Abacavir and increased risk of myocardial infarction Lancet (2008) 372; 803; author reply 04-5 F. A. Post and L. J. Campbell ST-segment elevation myocardial infarction with concomitant multiple coronary arteries thromboses in a young patient with hyperhomocysteinaemia Heart (2008) 94; 1180 L. Politi, D. E. Monopoli and M. G. Modena The measurement of plasma aldosterone in patients post-myocardial infarction Eur Heart J (2008) 29; 2451-2 B. Pitt Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials Catheter Cardiovasc Interv (2009) F. Piscione, R. Piccolo, S. Cassese, G. Galasso and M. Chiariello Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study) Am J Cardiol (2008) 101; 303-7 D. S. Pinto, A. J. Kirtane, Y. B. Pride, S. A. Murphy, M. S. Sabatine, C. P. Cannon and C. M. Gibson The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial Eur Heart J (2008) 29; 324-31 R. J. Peters, C. Joyner, J. P. Bassand, R. Afzal, S. Chrolavicius, S. R. Mehta, J. Oldgren, L. Wallentin, A. Budaj, K. A. Fox and S. Yusuf Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial Am Heart J (2008) 155; 388-94 G. Pedrazzini, E. Santoro, R. Latini, L. Fromm, M. G. Franzosi, T. Mocetti, L. Staszewsky, S. Barlera, G. Tognoni and A. P. Maggioni Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction Eur Heart J (2008) 29; 2489-96 B. R. Palmer, A. P. Pilbrow, C. M. Frampton, T. G. Yandle, L. Skelton, M. G. Nicholls and A. M. Richards Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease Circulation (2008) 118; 1047-56 C. B. Overgaard and V. Dzavik Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention Eur Heart J (2008) 29; 1241-9 P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, F. Saia, N. Taglieri, F. Baldazzi, S. Silenzi, M. L. Bacchi-Reggiani, P. Guastaroba, R. Grilli and A. Branzi Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment Eur Heart J (2008) 29; 315-23 J. Oldgren, L. Wallentin, R. Afzal, J. P. Bassand, A. Budaj, S. Chrolavicius, K. A. Fox, C. B. Granger, S. R. Mehta, P. Pais, R. J. Peters, D. Xavier, J. Zhu and S. Yusuf Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy Eur Heart J (2008) 29; 984-91 M. O'Donoghue, D. A. Morrow, C. P. Cannon, W. Guo, S. A. Murphy, C. M. Gibson and M. S. Sabatine Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction Am J Cardiol (2008) 101; 747-52 J. Nunez, E. Nunez, V. Bodi, J. Sanchis, G. Minana, L. Mainar, E. Santas, P. Merlos, E. Rumiz, H. Darmofal, A. M. Heatta and A. Llacer Gender disparity in cardiac procedures and medication use for acute myocardial infarction Am Heart J (2008) 155; 862-8 J. T. Nguyen, A. K. Berger, S. Duval and R. V. Luepker A simple prognostic classification model for postprocedural complications after percutaneous coronary intervention for acute myocardial infarction (from the New York State percutaneous coronary intervention database) Am J Cardiol (2009) 103; 937-42 A. Negassa, E. S. Monrad and V. S. Srinivas Predictors and time-related impact of distal embolization during primary angioplasty Eur Heart J (2009) 30; 305-13 M. Napodano, A. Ramondo, G. Tarantini, D. Peluso, S. Compagno, C. Fraccaro, A. C. Frigo, R. Razzolini and S. Iliceto Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction Eur Heart J (2008) 29; 445-54 M. Nahrendorf, E. Aikawa, J. L. Figueiredo, L. Stangenberg, S. W. van den Borne, W. M. Blankesteijn, D. E. Sosnovik, F. A. Jaffer, C. H. Tung and R. Weissleder Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry) Am J Cardiol (2009) 103; 583-7 C. K. Naber, R. H. Mehta, C. Junger, U. Zeymer, H. Wienbergen, G. V. Sabin, R. Erbel, J. Senges and A. Gitt Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease Am J Cardiol (2008) 102; 54-7 P. Muntner, D. Mann, J. Winston, S. Bansilal and M. E. Farkouh The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies Heart (2008) 94; e5 Z. Motovska, P. Widimsky and M. Aschermann Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque J Am Coll Cardiol (2008) 52; 1049-51 P. R. Moreno, K. R. Purushothaman, M. Purushothaman, P. Muntner, N. S. Levy, V. Fuster, J. T. Fallon, P. A. Lento, A. Winterstern and A. P. Levy Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet (2009) 373; 723-31 G. Montalescot, S. D. Wiviott, E. Braunwald, S. A. Murphy, C. M. Gibson, C. H. McCabe and E. M. Antman Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial Eur Heart J (2008) 29; 462-71 G. Montalescot, M. Cohen, G. Salette, W. J. Desmet, C. Macaya, P. E. Aylward, P. G. Steg, H. D. White, R. Gallo and S. R. Steinhubl Mechanical reperfusion: treat well, treat on time too Lancet (2008) 372; 509-10 G. Montalescot Is heart failure the critical warning sign for death following myocardial infarction? Eur Heart J (2008) 29; 833-4 J. E. Moller, C. Torp-Pedersen and L. V. Kober Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome Am J Cardiol (2008) 101; 573-8 E. Missel, G. S. Mintz, S. G. Carlier, K. Sano, J. Qian, R. K. Kaple, C. Castellanos, G. Dangas, R. Mehran, J. W. Moses, G. W. Stone and M. B. Leon Cytochrome P450 2C19 polymorphism and clopidogrel after MI Lancet (2009) 373; 1171-2; author reply 72-3 J. Miao, R. Liu and Z. Li Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study Eur Heart J (2009) 30; 56-65 A. Meris, M. Amigoni, H. Uno, J. J. Thune, A. Verma, L. Kober, M. Bourgoun, J. J. McMurray, E. J. Velazquez, A. P. Maggioni, J. Ghali, J. M. Arnold, S. Zelenkofske, M. A. Pfeffer and S. D. Solomon Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes Am Heart J (2008) 156; 209-15 C. Melloni, K. P. Alexander, A. Y. Chen, L. K. Newby, M. T. Roe, N. M. Allen LaPointe, C. V. Pollack, Jr., W. B. Gibler, E. M. Ohman and E. D. Peterson The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial Eur Heart J (2008) 29; 166-76 L. G. Mellbin, K. Malmberg, A. Norhammar, H. Wedel and L. Ryden Transient ST-elevation myocardial infarction: clinical course with intense medical therapy and early invasive approach, and comparison with persistent ST-elevation myocardial infarction Am Heart J (2008) 155; 848-54 S. R. Meisel, Y. Dagan, D. S. Blondheim, S. Dacca, M. Shochat, M. Kazatsker, A. Asif, A. Frimerman and A. Shotan A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale Am Heart J (2008) 155; 600-8 R. H. Mehta, J. H. Alexander, R. Emery, S. J. Ellis, V. Hasselblad, A. Khalil, M. Carrier, R. A. Harrington and J. C. Tardif Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J (2009) R. Mehran, S. J. Pocock, G. W. Stone, T. C. Clayton, G. D. Dangas, F. Feit, S. V. Manoukian, E. Nikolsky, A. J. Lansky, A. Kirtane, H. D. White, A. Colombo, J. H. Ware, J. W. Moses and E. M. Ohman The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale Am Heart J (2008) 156; 44-56 R. Mehran, B. Brodie, D. A. Cox, C. L. Grines, B. Rutherford, D. L. Bhatt, G. Dangas, F. Feit, E. M. Ohman, H. Parise, M. Fahy, A. J. Lansky and G. W. Stone Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study Lancet (2008) 372; 224-33 M. J. McQueen, S. Hawken, X. Wang, S. Ounpuu, A. Sniderman, J. Probstfield, K. Steyn, J. E. Sanderson, M. Hasani, E. Volkova, K. Kazmi and S. Yusuf Comparison of outcomes and safety of "facilitated" versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction Am J Cardiol (2009) 103; 316-21 R. G. McKay, M. R. Dada, J. F. Mather, R. R. Mennet, D. J. Murphy, K. W. Maloney, J. A. Hirst and F. J. Kiernan Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial Eur Heart J (2008) 29; 394-401 E. O. McFalls, H. B. Ward, T. E. Moritz, F. S. Apple, S. Goldman, G. Pierpont, G. C. Larsen, B. Hattler, K. Shunk, F. Littooy, S. Santilli, J. Rapp, L. Thottapurathu, W. Krupski, D. J. Reda and W. G. Henderson Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin Eur Heart J (2008) 29; 2843-50 T C. J. McCann, B. M. Glover, I. B. Menown, M. J. Moore, J. McEneny, C. G. Owens, B. Smith, P. C. Sharpe, I. S. Young and J. A. Adgey Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction Am J Cardiol (2008) 102; 524-9 S. Matetzky, P. Fefer, B. Shenkman, D. Varon, N. Savion and H. Hod Acute myocardial infarction and mechanical complications due to a penetrating knife injury of the heart Eur Heart J (2008) 29; 1806 R. Martin-Reyes, M. A. Navas Lobato, R. Peinado, A. Sanchez-Recalde, R. Moreno, M. M. Yanguela, J. L. Lopez Sendon and I. G. Blazquez Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review Eur Heart J (2008) 29; 1807-18 E. Martin-Rendon, S. J. Brunskill, C. J. Hyde, S. J. Stanworth, A. Mathur and S. M. Watt Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network Eur Heart J (2008) 29; 1834-42 A. Manari, P. Ortolani, P. Guastaroba, G. Casella, L. Vignali, E. Varani, G. Piovaccari, V. Guiducci, G. Percoco, S. Tondi, F. Passerini, A. Santarelli and A. Marzocchi Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT) Am Heart J (2009) 157; 724-32 L. A. Malek, H. R. Reynolds, S. A. Forman, C. Vozzi, G. B. Mancini, J. K. French, M. Dziarmaga, J. P. Renkin, J. Kochman, G. A. Lamas and J. S. Hochman In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction Eur Heart J (2008) 29; 2201 M. R. Makowski, U. Ebersberger, S. Nekolla and M. Schwaiger Cell therapy in acute myocardial infarction: measures of efficacy Heart (2008) 94; 969-70 K. Lunde and S. Aakhus High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis Am Heart J (2008) 155; 954-8 A. Lotfi, M. J. Schweiger, G. R. Giugliano, S. A. Murphy and C. P. Cannon Hormone therapy and risk of myocardial infarction: a national register study Eur Heart J (2008) 29; 2660-8 E. Lokkegaard, A. H. Andreasen, R. K. Jacobsen, L. H. Nielsen, C. Agger and O. Lidegaard Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease Am J Cardiol (2009) 103; 476-81 Y. Liu, X. Li, D. Peng, Z. Tan, H. Liu, Y. Qing, Y. Xue and G. P. Shi Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes Heart J (2008) 155; 718-24 K. D. Lim, A. T. Yan, A. Casanova, R. T. Yan, A. Mendelsohn, S. Jolly, D. H. Fitchett, A. Langer and S. G. Goodman Am Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction Eur Heart J (2008) 29; 1949-55 F. Leuschner, J. Li, S. Goser, L. Reinhardt, R. Ottl, P. Bride, J. Zehelein, G. Pfitzer, A. Remppis, E. Giannitsis, H. A. Katus and Z. Kaya Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome Am Heart J (2008) 156; 177-84 S. Leung, D. Gallup, K. W. Mahaffey, M. Cohen, E. M. Antman, S. G. Goodman, R. A. Harrington, A. Langer, P. Aylward, J. J. Ferguson and R. M. Califf Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial Catheter Cardiovasc Interv (2008) 72; 25-32 J. H. Lee, H. S. Kim, S. W. Lee, J. H. Park, S. W. Choi, J. O. Jeong, Y. Cho, N. Lee, K. S. Rhee, J. K. Ko and I. W. Seong The universal definition of myocardial infarction: some issues and concerns Eur Heart J (2008) 29; 1209; author reply 09-10 G. A. Lanza Day-night variation of acute myocardial infarction in obstructive sleep apnea J Am Coll Cardiol (2008) 52; 343-6 F. H. Kuniyoshi, A. Garcia-Touchard, A. S. Gami, A. Romero-Corral, C. van der Walt, S. Pusalavidyasagar, T. Kara, S. M. Caples, G. S. Pressman, E. C. Vasquez, F. Lopez-Jimenez and V. K. Somers External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention Heart (2008) 94; 1012-8 B. Kunadian, J. Dunning, R. Das, A. P. Roberts, R. Morley, A. J. Turley, D. Twomey, J. A. Hall, R. A. Wright, A. G. Sutton, D. F. Muir and M. A. de Belder Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction. First-in-man study Heart (2009) K. Krause, K. Jaquet, C. Schneider, M. Lioznov, K. M. Otte, S. Haupt and K. H. Kuck Combined prognostic utility of white blood cell count, plasma glucose, and glomerular filtration rate in patients undergoing primary stent placement for acute myocardial infarction Am J Cardiol (2009) 103; 322-7 M. Kosuge, K. Kimura, S. Morita, S. Kojima, T. Sakamoto, M. Ishihara, Y. Asada, C. Tei, S. Miyazaki, M. Sonoda, K. Tsuchihashi, M. Yamagishi, M. Shirai, H. Hiraoka, T. Honda, Y. Ogata and H. Ogawa Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction Eur Heart J (2008) 29; 2851-8 M. Korf-Klingebiel, T. Kempf, T. Sauer, E. Brinkmann, P. Fischer, G. P. Meyer, A. Ganser, H. Drexler and K. C. Wollert Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve Eur Heart J (2008) 29; 726-32 B. K. Koo, K. W. Park, H. J. Kang, Y. S. Cho, W. Y. Chung, T. J. Youn, I. H. Chae, D. J. Choi, S. J. Tahk, B. H. Oh, Y. B. Park and H. S. Kim DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study Eur Heart J (2008) 29; 1250-8 M. Kolz, W. Koenig, M. Muller, M. Andreani, S. Greven, T. Illig, N. Khuseyinova, D. Panagiotakos, G. Pershagen, V. Salomaa, J. Sunyer and A. Peters Identification of multiple plaque ruptures by optical coherence tomography in a patient with acute myocardial infarction: a three-vessel study Heart (2008) 94; 544 H. Kitabata, T. Kubo and T. Akasaka Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction Eur Heart J (2009) S. Q. Khan, K. Ng, O. Dhillon, D. Kelly, P. Quinn, I. B. Squire, J. E. Davies and L. L. Ng Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial J Am Coll Cardiol (2008) 51; 899-905 H. Kelbaek, C. J. Terkelsen, S. Helqvist, J. F. Lassen, P. Clemmensen, L. Klovgaard, A. Kaltoft, T. Engstrom, H. E. Botker, K. Saunamaki, L. R. Krusell, E. Jorgensen, H. H. Hansen, E. H. Christiansen, J. Ravkilde, L. Kober, K. F. Kofoed and L. Thuesen Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction Eur Heart J (2008) 29; 1485-94 S. Kasama, M. Furuya, T. Toyama, S. Ichikawa and M. Kurabayashi Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction Heart (2008) 94; 604-9 H. J. Kang, Y. S. Kim, B. K. Koo, K. W. Park, H. Y. Lee, D. W. Sohn, B. H. Oh, Y. B. Park and H. S. Kim Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease: Ischaemic heart disease Heart (2008) 94; 1080-8 N. Johnston, H. Dargie and A. Jardine ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3 Am J Cardiol (2009) 103; 154-8 P. Johanson, Y. Fu, G. S. Wagner, S. G. Goodman, C. B. Granger, L. Wallentin, F. Van de Werf and P. W. Armstrong Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea Circulation (2008) 117; 2270-8 S. Jelic, M. Padeletti, S. M. Kawut, C. Higgins, S. M. Canfield, D. Onat, P. C. Colombo, R. C. Basner, P. Factor and T. H. LeJemtel Alcohol and long-term prognosis after a first acute myocardial infarction: the SHEEP study I. Eur Heart J (2008) 29; 45-53 Janszky, R. Ljung, S. Ahnve, J. Hallqvist, A. M. Bennet and K. J. Mukamal Role of percutaneous coronary minimalist intervention in the management of acute ST-segment elevation myocardial infarction J Am Coll Cardiol (2008) 51; 1046-7; author reply 47 K. Isaaz Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis Heart (2008) 94; 610-6 H. Ince, M. Valgimigli, M. Petzsch, J. S. de Lezo, F. Kuethe, S. Dunkelmann, G. Biondi-Zoccai and C. A. Nienaber Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention Eur Heart J (2009) 30; 290-6 R. Iijima, G. Ndrepepa, J. Mehilli, R. A. Byrne, S. Schulz, F. J. Neumann, G. Richardt, P. B. Berger, A. Schomig and A. Kastrati Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction Eur Heart J (2009) 30; 689-98 H. V. Huikuri, M. J. Raatikainen, R. Moerch-Joergensen, J. Hartikainen, V. Virtanen, J. Boland, O. Anttonen, N. Hoest, L. V. Boersma, E. S. Platou, M. D. Messier and P. E. Bloch-Thomsen Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction Eur Heart J (2008) 29; 2723-32 H. V. Huikuri, K. Kervinen, M. Niemela, K. Ylitalo, M. Saily, P. Koistinen, E. R. Savolainen, H. Ukkonen, M. Pietila, J. K. Airaksinen, J. Knuuti and T. H. Makikallio The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP) Heart (2009) 95; 559-63 S. Horne, C. Weston, T. Quinn, A. Hicks, L. Walker, R. Chen and J. Birkhead B-type natriuretic peptide infusions in acute myocardial infarction Heart (2008) 94; 617-22 R. J. Hillock, C. M. Frampton, T. G. Yandle, R. W. Troughton, J. G. Lainchbury and A. M. Richards Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction Eur Heart J (2008) 29; 2265-75 G. Heusch, A. Skyschally, P. Gres, P. van Caster, D. Schilawa and R. Schulz Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study Eur Heart J (2009) 30; 662-70 L. Herbots, J. D'Hooge, E. Eroglu, D. Thijs, J. Ganame, P. Claus, C. Dubois, K. Theunissen, J. Bogaert, J. Dens, M. Kalantzi, S. Dymarkowski, B. Bijnens, A. Belmans, M. Boogaerts, G. Sutherland, F. Van de Werf, F. Rademakers and S. Janssens Comparison of multislice computed tomography to gated single-photon emission computed tomography for imaging of healed myocardial infarcts Am J Cardiol (2008) 101; 144-8 M. M. Henneman, J. D. Schuijf, P. Dibbets-Schneider, M. P. Stokkel, R. J. van der Geest, E. E. van der Wall and J. J. Bax Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? Eur Heart J (2008) 29; 299-314 S. A. Hayat and R. Senior Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction Am Heart J (2009) 157; 763-70 A. Goyal, S. R. Mehta, H. C. Gerstein, R. Diaz, R. Afzal, D. Xavier, J. Zhu, P. Pais, L. Lisheng, K. A. Kazmi, M. Zubaid, L. S. Piegas, P. Widimsky, A. Budaj, A. Avezum and S. Yusuf Clot removal in AMI--worth the hassle? Heart (2008) 94; 258-9 D. A. Gorog and I. Malik Suggestion to list acute aortic dissection as a possible cause of type 2 myocardial infarction (according to the universal definition) Eur Heart J (2008) 29; 2819-20 K. P. Goran Abacavir and increased risk of myocardial infarction Lancet (2008) 372; 803-4; author reply 04-5 M. Goicoechea and A. McCutchan Acute reperfusion strategies for ST-segment elevation myocardial infarction Eur Heart J (2008) 29; 571-2 B. M. Glover and A. A. Adgey Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy Am J Cardiol (2008) 101; 1232-8 C. M. Gibson, Y. B. Pride, J. L. Buros, V. Kunadian, M. C. Southard, C. J. Harrigan, L. N. Ciaglo, M. S. Sabatine, C. P. Cannon and E. Braunwald Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study Am Heart J (2008) 155; 133-9 C. M. Gibson, S. A. Murphy, Y. B. Pride, A. J. Kirtane, J. M. Aroesty, E. B. Stein, L. N. Ciaglo, M. C. Southard, M. S. Sabatine, C. P. Cannon and E. Braunwald Managing myocardial infarction in the elderly: time to bury inappropriate concerns instead Eur Heart J (2009) A. H. Gershlick Ten-year all-cause mortality in presumably healthy subjects on lipid-lowering drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort) Am J Cardiol (2009) 103; 381-6 V. Gardette, V. Bongard, J. Dallongeville, D. Arveiler, A. Bingham, J. B. Ruidavets, P. Amouyel, B. Haas, P. Ducimetiere and J. Ferrieres Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction Eur Heart J (2009) J. Ganame, G. Messalli, S. Dymarkowski, F. E. Rademakers, W. Desmet, F. Van de Werf and J. Bogaert Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database Heart (2009) 95; 221-7 C. P. Gale, S. O. Manda, C. F. Weston, J. S. Birkhead, P. D. Batin and A. S. Hall Predominant subepicardial enhancement on magnetic resonance imaging corresponding to a post-infarction acute pericarditis in an athletic young patient Eur Heart J (2008) 29; 2876 G. Gahide, R. Gervasoni and F. Roubille Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: a Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy Am Heart J (2008) 156; 391-6 E. L. Fosbol, J. J. Thune, H. Kelbaek, H. R. Andersen, K. Saunamaki, T. T. Nielsen, L. S. Mortensen and L. Kober Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT Eur Heart J (2008) 29; 260-9 H. Fonge, K. Vunckx, H. Wang, Y. Feng, L. Mortelmans, J. Nuyts, G. Bormans, A. Verbruggen and Y. Ni Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction Eur Heart J (2009) M. L. Fokkema, P. J. Vlaar, T. Svilaas, M. Vogelzang, D. Amo, G. F. Diercks, A. J. Suurmeijer and F. Zijlstra Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study Eur Heart J (2008) 29; 1966-74 J. P. Empana, F. Canoui-Poitrine, G. Luc, I. Juhan-Vague, P. Morange, D. Arveiler, J. Ferrieres, P. Amouyel, A. Bingham, M. Montaye, J. B. Ruidavets, B. Haas, A. Evans and P. Ducimetiere Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial Eur Heart J (2008) 29; 1625-34 S. G. Ellis, C. D. O'Shaughnessy, S. L. Martin, K. Kent, T. McGarry, M. A. Turco, D. J. Kereiakes, J. J. Popma, M. Friedman, J. Koglin and G. W. Stone Abacavir and increased risk of myocardial infarction Lancet (2008) 372; 805 R. Edwards, A. Bate and M. Lindquist The pharmaco-invasive approach to STEMI: when should fibrinolytic-treated patients go to the "cath lab"? Heart (2009) 95; 358-61 J. J. Edmond, C. P. Juergens and J. K. French Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go Eur Heart J (2008) 29; 609-17 K. A. Eagle, B. K. Nallamothu, R. H. Mehta, C. B. Granger, P. G. Steg, F. Van de Werf, J. Lopez-Sendon, S. G. Goodman, A. Quill and K. A. Fox President's page: responding to the drum beat for health care reform J Am Coll Cardiol (2008) 51; 1042-3 J. T. Dove Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock Am J Cardiol (2008) 101; 1537-40 A. Dominguez-Rodriguez, S. Samimi-Fard, P. Abreu-Gonzalez, M. J. Garcia-Gonzalez and J. C. Kaski Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy Am Heart J (2009) 157; 541-7 T. Dill, V. Schachinger, A. Rolf, S. Mollmann, H. Thiele, H. Tillmanns, B. Assmus, S. Dimmeler, A. M. Zeiher and C. Hamm Cardiac magnetic resonance and 64-slice cardiac CT of lipomatous metaplasia of chronic myocardial infarction Eur Heart J (2008) 29; 570 J. F. Deux, A. Rahmouni and J. Garot Risk factor management after myocardial infarction: reported adherence and outcomes Am Heart J (2009) 157; 556-62 C. Decker, H. Ahmad, K. L. Moreng, T. M. Maddox, K. J. Reid, P. G. Jones and J. A. Spertus Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis Heart (2008) 94; 1548-58 G. De Luca, C. M. Gibson, F. Bellandi, S. Murphy, M. Maioli, M. Noc, U. Zeymer, D. Dudek, H. R. Arntz, S. Zorman, H. M. Gabriel, A. Emre, D. Cutlip, G. Biondi-Zoccai, T. Rakowski, M. Gyongyosi, P. Marino, K. Huber and A. W. van't Hof Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial) Am Heart J (2008) 155; 1090-6 G. Dangas, G. W. Stone, M. D. Weinberg, J. Webb, D. A. Cox, B. R. Brodie, M. W. Krucoff, R. J. Gibbons, A. J. Lansky and R. Mehran Pre-hospital thrombolysis in perspective Eur Heart J (2008) 29; 2835-42 N. Danchin, E. Durand and D. Blanchard Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI) Circulation (2008) 118; 268-76 N. Danchin, P. Coste, J. Ferrieres, P. G. Steg, Y. Cottin, D. Blanchard, L. Belle, B. Ritz, G. Kirkorian, M. Angioi, P. Sans, B. Charbonnier, H. Eltchaninoff, P. Gueret, K. Khalife, P. Asseman, J. Puel, P. Goldstein, J. P. Cambou and T. Simon Challenging doctors' lifelong habits may be good for their patients: oxygen therapy in acute myocardial infarction Heart (2009) 95; 176-7 N. Danchin and D. Chemla PCI at non-PCI centres: immediate or rescue? Lancet (2008) 371; 534-6 N. Danchin and P. W. Armstrong Abacavir and the potential risk of myocardial infarction Lancet (2008) 371; 1413 A. Cutrell, C. Brothers, J. Yeo, J. Hernandez and D. Lapierre Physical exertion and triggering of myocardial infarction Heart J (2009) 30; 250; author reply 50-1 V. Culic Eur Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study Lancet (2009) 373; 309-17 J. P. Collet, J. S. Hulot, A. Pena, E. Villard, J. B. Esteve, J. Silvain, L. Payot, D. Brugier, G. Cayla, F. Beygui, G. Bensimon, C. Funck-Brentano and G. Montalescot Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up Am Heart J (2008) 155; 128-32 M. Co, E. Tay, C. H. Lee, K. K. Poh, A. Low, J. Lim, I. H. Lim, Y. T. Lim and H. C. Tan Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study J Am Coll Cardiol (2008) 52; 1104-5 J. G. Cleland, I. Squire and L. Ng Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction Circulation (2009) 119; 1195-202 S. Cheng, D. A. Morrow, S. Sloan, E. M. Antman and M. S. Sabatine Explaining trends in coronary heart disease hospitalisations in New Zealand: trend for admissions and incidence can be in opposite directions Heart (2008) 94; 1589-93 W. C. Chan, C. Wright, M. Tobias, S. Mann and R. Jackson Impact of coronary revascularization and transmural extent of scar on regional left ventricular remodelling Eur Heart J (2008) 29; 1608-17 J. Chan, F. Khafagi, A. A. Young, B. R. Cowan, C. Thompson and T. H. Marwick Atrial fibrillation complicating acute myocardial infarction: how should it be interpreted and how should it be treated and prevented? Eur Heart J (2009) R. Cappato Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) Am Heart J (2008) 155; 19-25 W. J. Cantor, D. Fitchett, B. Borgundvaag, M. Heffernan, E. A. Cohen, L. J. Morrison, J. Ducas, A. Langer, S. Mehta, C. Lazzam, B. Schwartz, V. Dzavik and S. G. Goodman Why do men and women differ in their risk of myocardial infarction? Eur Heart J (2008) 29; 835-6 D. J. Campbell Giant left ventricular pseudoaneurysm: a rare complication following left ventricular rupture caused by myocardial infarction Eur Heart J (2008) 29; 143 T. Butz, L. Faber, C. Langer and D. Horstkotte ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Circulation (2008) 118; 1335-46 C. E. Buller, Y. Fu, K. W. Mahaffey, T. G. Todaro, P. Adams, C. M. Westerhout, H. D. White, A. W. van 't Hof, F. J. Van de Werf, G. S. Wagner, C. B. Granger and P. W. Armstrong Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study Heart (2009) 95; 461-7 B. Buckley and A. W. Murphy Oedema in acute myocardial infarction Eur Heart J (2008) 29; 1249 C. Bucciarelli-Ducci and D. J. Pennell Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial Am Heart J (2008) 155; 1039-46 M. A. Brouwer, P. C. Kievit, H. J. Dieker, G. Veen, A. J. Karreman and F. W. Verheugt Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group Catheter Cardiovasc Interv (2008) 72; 893-900 B. R. Brodie, T. Stuckey, W. Downey, A. Humphrey, M. Nussbaum, S. Laurent, B. Bradshaw, C. Metzger, J. Hermiller, F. Krainin, S. Juk, B. Cheek, P. Duffy and C. A. Simonton What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice? Catheter Cardiovasc Interv (2008) 71; 816-21 B. R. Brodie A dangerous bridge: myocardial infarction due to myocardial bridging in left ventricular hypertrophy Eur Heart J (2008) 29; 839 H. Bonnemeier and M. Barantke Thrombus aspiration during percutaneous coronary intervention Lancet (2008) 372; 1034; author reply 34-5 L. Bonello, A. De Labriolle, D. Steinberg and R. Waksman Duration of symptoms is not always the key modulator of the choice of reperfusion for ST-elevation myocardial infarction Circulation (2009) 119; 1304-10 P. Bogaty Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004 Heart (2009) 95; 304-11 H. M. Blackledge and I. B. Squire Acute coronary syndromes: to CRP or not to CRP? J Am Coll Cardiol (2008) 52; 1500; author reply 00-1 L. M. Biasucci, G. Liuzzo and F. Crea Cytochrome P450 2C19 polymorphism and clopidogrel after MI Lancet (2009) 373; 1171; author reply 72-3 S. Bhattacharyya and R. Rakhit Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitaliere, l'Evolution a un an et les caRacteristiques de patients presentant un infArctus du myocarde avec ou sans onde Q (OPERA) study Am Heart J (2009) 157; 680-7 F. Beygui, G. Montalescot, E. Vicaut, S. Rouanet, E. Van Belle, C. Baulac, A. Degrandsart and J. Dallongeville Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT) Eur Heart J (2009) C. Berry, K. S. Pieper, H. D. White, S. D. Solomon, F. Van de Werf, E. J. Velazquez, A. P. Maggioni, R. M. Califf, M. A. Pfeffer and J. J. McMurray Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III) Am Heart J (2008) 155; 817-22 A. M. Belonje, A. A. Voors, W. H. van Gilst, S. D. Anker, R. H. Slart, R. A. Tio, F. Zijlstra and D. J. van Veldhuisen Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials Eur Heart J (2008) 29; 2989-3001 A. A. Bavry, D. J. Kumbhani and D. L. Bhatt Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk) Eur Heart J (2009) 30; 576-83 A. Bauer, P. Barthel, R. Schneider, K. Ulm, A. Muller, A. Joeinig, R. Stich, A. Kiviniemi, K. Hnatkova, H. Huikuri, A. Schomig, M. Malik and G. Schmidt Hunting rifle shot to the chest: a rare cause of myocardial infarction Eur Heart J (2008) 29; 1652 A. E. Baruteau, R. P. Martins and D. Boulmier Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy Am Heart J (2008) 156; 241-7 S. Bangalore, F. H. Messerli, J. D. Cohen, P. H. Bacher, P. Sleight, G. Mancia, P. Kowey, Q. Zhou, A. Champion and C. J. Pepine Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study Heart (2008) 94; 1559-64 J. H. Bae, T. G. Kwon, D. W. Hyun, C. S. Rihal and A. Lerman Drug-eluting stents: do the risks really outweigh the benefits? Heart (2008) 94; 127-8 D. Austin, J. P. Pell and K. G. Oldroyd Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction Circulation (2009) 119; 1293-303 P. W. Armstrong, C. M. Westerhout and R. C. Welsh A comparison between B-type natriuretic peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification Heart (2009) D. S. Ang, L. Wei, M. P. Kao, C. C. Lang and A. D. Struthers Risk factors for myocardial infarction in women and men: insights from the INTERHEART study Eur Heart J (2008) 29; 932-40 S. S. Anand, S. Islam, A. Rosengren, M. G. Franzosi, K. Steyn, A. H. Yusufali, M. Keltai, R. Diaz, S. Rangarajan and S. Yusuf Spontaneous coronary artery dissection: diagnosis by optical coherence tomography Eur Heart J (2009) 30; 385 F. Alfonso, E. Canales and G. Aleong Rural interhospital transfer of ST-elevation myocardial infarction patients for percutaneous coronary revascularization: the Stat Heart Program Circulation (2008) 117; 1145-52 F. V. Aguirre, J. J. Varghese, M. P. Kelley, W. Lam, C. L. Lucore, J. B. Gill, L. Page, L. Turner, C. Davis and F. L. Mikell No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction Eur Heart J (2008) 29; 1795-7 A. Abbate, M. C. Kontos and G. G. Biondi-Zoccai